IL6 and systemic-onset juvenile idiopathic arthritis: Since most patients with SJIA demonstrate an excellent response to glucocorticoid, anti-IL-1 or anti-IL-6 therapy, the lack of such a response should prompt reconsideration of the diagnosis of SJIA (statement 3D) [12–14, 33].